I
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Cayman Islands
Recent Filings
- 8-K275.2 KBIBERE PHARMACEUTICALSFeb 15, 10:42 AM ET·0001104659-23-022265
- SC 13G66.4 KBIBERE PHARMACEUTICALSFeb 14, 12:36 PM ET·0001076809-23-000098
- SC 13G/A137.4 KBIBERE PHARMACEUTICALSFeb 14, 8:14 AM ET·0001104659-23-020776
- SC 13G61.4 KBIBERE PHARMACEUTICALSFeb 8, 3:19 PM ET·0001393825-23-000095
- SC 13G/A45.9 KBIBERE PHARMACEUTICALSFeb 8, 2:09 PM ET·0000899140-23-000137
- SC 13G/A136.7 KBIBERE PHARMACEUTICALSFeb 2, 11:10 AM ET·0001104659-23-009731
- 10-Q5.2 MBIBERE PHARMACEUTICALSNov 14, 3:48 PM ET·0001410578-22-003339
- 10-Q5.0 MBIBERE PHARMACEUTICALSAug 12, 4:13 PM ET·0001410578-22-002405
- 10-Q4.3 MBIBERE PHARMACEUTICALSMay 16, 1:42 PM ET·0001410578-22-001616
- 10-K5.4 MBIBERE PHARMACEUTICALSMar 31, 4:48 PM ET·0001410578-22-000776
Insiders
8Tickers
No tickers on record
Addresses
business
2005 MARKET STREET, SUITE 2030
PHILADELPHIA, PA, 19103
mailing
2005 MARKET STREET, SUITE 2030
PHILADELPHIA, PA, 19103